The primary application of the Ciclesonide Market is the research, manufacturing, and sales of ciclesonide, which is a corticosteroid that is used, most often, for the prevention or cure of asthma or allergic rhinitis. Ciclesonide is used inhaled or in the form of nasal spray; it has proved to be very effective in the treatment of inflammation in respiratory tracts other than being absorbed systemically through the bloodstream which limits its use other than in short-term respiratory ailment treatments.

Pharmacovigilance Market Size Was Valued at USD 7.42 Billion in 2023, and is Projected to Reach USD 23.45 Billion by 2032, Growing at a CAGR of 13.8% From 2024-2032.